You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1 to 25 of about 5856
Next 25
02/12/2025
Musella Foundation Brain Tumor Treatment Copayment Assistance Program is now closed to new patients
02/10/2025
Targepeutics Receives Rare Pediatric Disease Designation from FDA for GB13
02/05/2025
Curtana Pharmaceuticals Announces Breakthrough in Pediatric Brain Cancer Treatment with Dual Studies Published in Nature Communications
02/04/2025
College Scholarship for Brain and Spinal Cord Tumor Survivors Now Open
01/27/2025
Recent Imaging Biometrics webinar on Oral Gallium Maltolate
Musella Foundation Copayment Assistance Program Closing Soon
Webinar Tomorrow: Using ultrasound technology to open the blood-brain barrier
01/20/2025
Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: does time of administration matter?
Upcoming Webinar: Using ultrasound technology to open the blood-brain barrier
Musella Foundation Low Grade Brain Tumor Guide
Summer Fellowships in Neuroscience
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma
01/06/2025
Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort
12/30/2024
Webinar on sonodynamic therapy for brain tumors now available
Musella Foundation awards 2 more research grants
Highlights from SNO 2024!
12/01/2024
Upcoming webinar: Sonodynamic therapy using focused ultrasound for people with gliomas
Treatment-related survival patterns in diffuse intrinsic pontine glioma using a historical cohort: A report from the European Society for Pediatric Oncology DIPG/DMG Registry
Musella Foundation 2024 Highlights
Advocacy Alert! Ensuring Patient Access to Critical Breakthrough Products Act: H.R. 1691 and S. 5349
11/25/2024
IQ-AI adds key board member as its Imaging Biometrics subsidiary expands GE partnership
Eflornithine and Lomustine Combination Shows Clinically Meaningful Improvements in Overall Survival (OS) and Progression Free Survival (PFS) in Patients with Recurrent Astrocytoma IDH Mutant Grade 3
Phase 1 Trial of Personalized Neoantigen Vaccines in Combination with Standard of Care To Treat Glioblastoma
Alpheus Medical Announces Positive Phase 1/2 Trial Results for the Treatment of Recurrent High-Grade Gliomas
11/08/2024
UNC Lineberger brings investigative cancer treatment for glioblastoma patients in Southeastern US